leisure time -WSS

leisure time

author：explore 2025-09-06 04:38:12 - browse：15

Adam's take main illustration — Molly Ferguson/STAT

For two days starting on Sunday, Moonlake Immunotherapeutics happily crunched numbers and shared results from a mid-stage clinical trial that depicted its experimental antibody in the most flattering terms possible.

The drug, called sonelokimab, was “changing the game” for the treatment of a debilitating skin condition called hidradenitis suppurativa, or HS, said Moonlake CEO Jorge Santos da Silva, on a call for investors and analysts. The drug’s benefit for patients placed it “at the top of the heap,” he added.

For other, equally important data from the same study that did not fit Moonlake’s home-run narrative, the company took a DIY approach. Curious about how sonelokimab performed against a treatment that’s already approved for HS? Pull out a calculator and do the math yourself. How badly did a higher dose of the drug underperform a lower dose? Take a guess.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen
Next article： Too many hospitalized Covid

Wikipedia

WSS

Covid silver lining: Unprecedented look at human immune system

Pancreatic cancer is often deadly, but new discoveries are raising hope

Oral obesity drug from Viking Therapeutics hits key early target

Alzheimer's risk factor APOE4 may be a distinct form of the disease

Young boy dies in trial for Pfizer Duchenne gene therapy

Readout Newsletter: Amylyx, Aurinia, and IQVIA

hotspot

leisure time

explore

Heart attack and stroke risk calculators need revising

Tome Biosciences co

Dobbs anniversary: the lost opportunity of abortion as health care

Having children helps parents live longer, especially after age 80

As demand for Covid shots wanes, Moderna seeks its next success

ACIP vaccine advisory panel sees its vacancies filled

Affirmative action in medical school literally saved lives

AMAs digital advisors table RPM coding reform proposal, again

Duchenne breakthrough therapy leaves behind pioneering families

People with mental disorders often marry others with same

explore

Too many hospitalized Covid

Ebola vaccine can save some who are already sick, per new study

Gut bacteria may contribute to kidney autoimmunity, study finds

Artificial intelligence use in health care faces greater scrutiny in 2024

Artificial intelligence use in health care faces greater scrutiny in 2024

Oral obesity drug from Viking Therapeutics hits key early target

Wikipedia

hotspot

Wikipedia

leisure time